The case in front of me: ecnoglutide · 40 °C. I have done this once and I suspect I got away with it rather than got it right. For context: I keep records of every…
All questions
Newest first. 5.2k questions across 107 tags.
The case in front of me: Nantong · Norway. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
Conditions: 10 mg · 5 mL. Please show the division. I want to check my own against yours. I would like the general form as well as the specific number, so I can apply…
For reference: 96.8% · PeptideMeter · 98.2%. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within what I…
For reference: 4 mg · 1.5 mL · phosphate-buffered diluent. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers…
For reference: SURMOUNT-OSA · hair thinning · 10 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is…
The specifics, since they change the answer: oral semaglutide · 1 mg/mL. I want a method I can write down and repeat, not a rule of thumb. I would rather…
For reference: 25 °C · semaglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned negative…
The particulars: 2 mg · semaglutide. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to reason…
Details up front: hair thinning · cagrilintide. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
Stated plainly: retatrutide · eight weeks · 37 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
Stated plainly: Janoshik · 96.8%. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have photographed the current…
What I am working with: QSC · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
What I am working with: retatrutide · 40 °C. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched…
Numbers first: 98.4% · Janoshik · 98.2%. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the…
The specifics, since they change the answer: racemisation · room temperature. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware…
Details up front: 95.2% · lot-specific certificate. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear…
Details up front: PIONEER-4 · early satiety. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
I am asking mechanistically rather than practically — I want the model, not the protocol. This is presented as though it settles something, and I am not convinced it…
The case in front of me: constipation · six · retatrutide. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already…
Conditions: semaglutide · seven days. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically, because…
Conditions: survodutide · 8 mg/mL. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write down, so…
The case in front of me: oxidation · minus 80 °C. This is one of those things that everyone repeats and nobody derives. This matters practically, not just…
My background is chemistry rather than physiology, which may explain where I am stuck. These are treated as interchangeable and I do not think they are. If both are…